Table III.

Multivariable multi-level logistic regression of specific vaccines and combination series for all cancer cases and specific cancer subtypes by use of county-level vaccination rates, Texas Cancer Registry, 1995–2006

	Total cases (n = 1707)			ALL (n = 547)			Non-Hodgkin lymphoma (n = 71)			Medulloblastoma (n = 70)
	OR*	P	95% CI	OR*	P	95% CI	OR*	P	95% CI	OR*	P	95% CI
DTaP†	1.20	.21	0.90–1.60	1.02	.92	0.61–1.72	2.34	.07	0.93–5.90	1.43	.55	0.44– 4.63
IPV‡	0.88	.17	0.74–1.05	0.67	.01	0.49–0.92	0.73	.47	0.31–1.72	1.47	.28	0.73– 2.96
MMR§	1.10	.48	0.84–1.45	0.84	.49	0.51–1.39	2.81	.01	1.27–6.22	1.20	.76	0.37– 3.88
Hib¶	0.92	.18	0.82–1.04	0.76	.13	0.54–1.08	0.98	.94	0.59–1.64	1.62	.05	1.00– 2.62
Hepatitis B**	0.81	.03	0.67–0.98	0.63	.006	0.46–0.88	0.77	.54	0.32–1.81	1.39	.38	0.67– 2.91
Varicella Zoster††	1.03	.60	0.92–1.16	1.07	.67	0.78–1.47	0.97	.91	0.58–1.62	0.90	.70	0.54– 1.51
4–3-1‡‡	1.00	.93	0.89–1.11	0.73	.10	0.51–1.06	1.13	.60	0.71–1.82	1.14	.69	0.60– 2.18
4–3-1–3-3§§	0.90	.28	0.74–1.09	0.62	.007	0.44–0.87	1.22	.72	0.40–3.69	1.58	.22	0.76– 3.30
4–3-1–3-3–1¶¶	0.98	.77	0.88–1.10	0.77	.22	0.50–1.17	0.84	.49	0.51–1.38	1.12	.74	0.58– 2.17

Bolded results denote significant results (P < .05) or borderline significant results (P = .05).

^*OR adjusted for sex, child’s birth year, child’s ethnicity, child’s birth weight, and mother’s age at child’s birth.

^†Four doses of the DTaP vaccine.

^‡Three doses of the IPV.

^§One dose of the MMR vaccine.

^¶Three doses of the Hib vaccine.

^**Three doses of the hepatitis B vaccine.

^††One dose of the varicella zoster vaccine.

^‡‡Four doses of the DTaP vaccine, three doses of the IPV, and one dose of the MMR vaccine.

^§§Four doses of the DTaP vaccine, three doses of the IPV, one dose of the MMR vaccine, and three doses of the Hib vaccine.

^¶¶Four doses of the DTaP vaccine, three doses of the IPV, one dose of the MMR vaccine, three doses of the Hib vaccine, three doses of the hepatitis B vaccine, and one dose of the varicella zoster vaccine.